- Home
- NUKK vs NRXS Comparison
NUKK vs NRXS Comparison
Compare NUKK & NRXS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NUKK
- NRXS
- Stock Information
- Founded
- NUKK 2013
- NRXS 2011
- Country
- NUKK United States
- NRXS United States
- Employees
- NUKK N/A
- NRXS N/A
- Industry
- NUKK Blank Checks
- NRXS
- Sector
- NUKK Finance
- NRXS
- Exchange
- NUKK Nasdaq
- NRXS Nasdaq
- Market Cap
- NUKK 25.4M
- NRXS 25.0M
- IPO Year
- NUKK N/A
- NRXS 2023
- Fundamental
- Price
- NUKK $5.33
- NRXS $2.56
- Analyst Decision
- NUKK
- NRXS Strong Buy
- Analyst Count
- NUKK 0
- NRXS 1
- Target Price
- NUKK N/A
- NRXS $7.00
- AVG Volume (30 Days)
- NUKK 11.5M
- NRXS 36.2K
- Earning Date
- NUKK 11-14-2025
- NRXS 11-11-2025
- Dividend Yield
- NUKK N/A
- NRXS N/A
- EPS Growth
- NUKK N/A
- NRXS N/A
- EPS
- NUKK N/A
- NRXS N/A
- Revenue
- NUKK N/A
- NRXS $3,217,531.00
- Revenue This Year
- NUKK N/A
- NRXS $62.14
- Revenue Next Year
- NUKK N/A
- NRXS $131.87
- P/E Ratio
- NUKK N/A
- NRXS N/A
- Revenue Growth
- NUKK N/A
- NRXS 41.93
- 52 Week Low
- NUKK $1.30
- NRXS $1.33
- 52 Week High
- NUKK $78.32
- NRXS $6.20
- Technical
- Relative Strength Index (RSI)
- NUKK 52.17
- NRXS 56.00
- Support Level
- NUKK $4.25
- NRXS $2.31
- Resistance Level
- NUKK $6.66
- NRXS $2.49
- Average True Range (ATR)
- NUKK 0.79
- NRXS 0.11
- MACD
- NUKK 0.23
- NRXS 0.01
- Stochastic Oscillator
- NUKK 47.31
- NRXS 67.57
About NUKK Nukkleus Inc.
Nukkleus Inc is a financial technology company that is focused on providing software and technology solutions. The company's operating segment includes General support services and Financial services. General support services include providing software, technology, customer sales and marketing, and risk management technology hardware and software solutions package under a GSA to a related party. Financial services include providing payment services from one fiat currency to another or to digital assets. It generates maximum revenue from the General support services segment. Geographically operates in USA, UK and Malta, with majority of revenue from United Kingdom (UK).
About NRXS Neuraxis Inc.
Neuraxis Inc is a growth stage company is engaged in developing neuromodulation therapies to address chronic and debilitating conditions in children. The company is dedicated to advancing the science with its' proprietary Percutaneous Electrical Nerve Field Stimulation (PENFS) technology. The company focuses on targeted therapies for the pediatric and adolescent population suffering from disorders of gut-brain interaction (DGBIs).